EOM Pharmaceuticals Holdings, Inc.
Other OTCTotal Valuation
EOM Pharmaceuticals Holdings, Inc. carries a market capitalization of 22.65M, placing it among publicly traded companies globally.
| Market Cap | 22.65M |
| Enterprise Value | N/A |
Share Statistics
EOM Pharmaceuticals Holdings, Inc. currently has 4.19M shares outstanding.
| Shares Outstanding | 4.19M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.07 |
| P/TBV Ratio | 2.51 |
| P/FCF Ratio | -0.79 |
| P/OCF Ratio | -0.79 |
Financial Position
EOM Pharmaceuticals Holdings, Inc. maintains a current ratio of 9.53, meaning it holds 9.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 9.53 |
| Quick Ratio | 8.31 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -131.11 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
EOM Pharmaceuticals Holdings, Inc.'s stock has gained approximately 221.54341% over the past 52 weeks. The 50-day moving average sits at 0.13, while the 200-day moving average is 0.13.
| Beta (5Y) | N/A |
| 52-Week Price Change | 221.54341% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.13 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -5.65M, while operating income came in at -5.66M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -5.66M |
| Pretax Income | -5.66M |
| Net Income | -5.66M |
| EBITDA | -5.65M |
| EBIT | -5.66M |
| Earnings Per Share (EPS) | -1.71 |
Balance Sheet
Total book value stands at -117.77M, with working capital of 3.43M providing operational flexibility.
| Cash & Cash Equivalents | 2.85M |
| Total Debt | N/A |
| Net Debt | -2.85M |
| Equity (Book Value) | -117.77M |
| Book Value Per Share | -35.64 |
| Working Capital | 3.43M |
Cash Flow
EOM Pharmaceuticals Holdings, Inc. produced -10.93M in operating cash flow over the past twelve months.
| Operating Cash Flow | -10.93M |
| Capital Expenditures | N/A |
| Free Cash Flow | -10.93M |
| FCF Per Share | -3.31 |
Dividends & Yields
The company's payout ratio of 28.83 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | 28.83 |
| Shareholder Yield | -139.29 |
| FCF Yield | -127.21 |
Stock Splits
EOM Pharmaceuticals Holdings, Inc.'s most recent stock split took place on September 16, 2020 with a 10:1 split ratio.
| Last Split Date | 9/16/2020 |
| Split Ratio | 10:1 |
Scores
EOM Pharmaceuticals Holdings, Inc. posts an Altman Z-Score of -34.05, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -34.05 |